RetinalGenix Technologies Inc. [OTCQB: RTGN] ('RetinalGenix” or the 'Company”), a company developing ultra-high-resolution ...

Gilbert Gee and Annie Ro depict systemic racism as the hidden base of an iceberg 10 (see illustration in online appendix exhibit 1). 11 The iceberg’s visible part represents the overt racism that ...

Objective Sjögren’s is a chronic systemic autoimmune disease characterised by dryness symptoms (eyes, mouth, skin), alongside ...

Zura with potential clinical validation of tibulizumab as a groundbreaking therapy in hidradenitis suppurativa (HS)Expanded Phase 2 TibuSHIELD trial in HS expected to deliver topline data in the ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...

Nutritional issues such as ARFID are highly prevalent among patients with SSc and can lead to poor outcomes and other ...

Patients with SSc were linked to an increased risk for hematological malignancies, specifically B-cell malignancies.

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...

Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and ...

Sheffield Teaching Hospitals NHS Foundation Trust has become the only site in the UK to open a groundbreaking international ...

LOS ANGELES, CALIFORNIA - JULY 24: Dr. Eric Esrailian speaks onstage during the 2025 Social Impact Summit by The Hollywood Reporter and Social Impact Fund on July 24, 2025 at the DGA in Los Angeles, ...

Please provide your email address to receive an email when new articles are posted on . Half of patients with systemic sclerosis demonstrated signs of disordered eating. Patients with SSc often manage ...